174 related articles for article (PubMed ID: 34954100)
1. Early Detection Initiative: A randomized controlled trial of algorithm-based screening in patients with new onset hyperglycemia and diabetes for early detection of pancreatic ductal adenocarcinoma.
Chari ST; Maitra A; Matrisian LM; Shrader EE; Wu BU; Kambadakone A; Zhao YQ; Kenner B; Rinaudo JAS; Srivastava S; Huang Y; Feng Z;
Contemp Clin Trials; 2022 Feb; 113():106659. PubMed ID: 34954100
[TBL] [Abstract][Full Text] [Related]
2. Cost-Effectiveness of a Risk-Tailored Pancreatic Cancer Early Detection Strategy Among Patients With New-Onset Diabetes.
Wang L; Scott FI; Boursi B; Reiss KA; Williams S; Glick H; Yang YX
Clin Gastroenterol Hepatol; 2022 Sep; 20(9):1997-2004.e7. PubMed ID: 34737092
[TBL] [Abstract][Full Text] [Related]
3. Validation of the ENDPAC model: Identifying new-onset diabetics at risk of pancreatic cancer.
Khan S; Safarudin RF; Kupec JT
Pancreatology; 2021 Apr; 21(3):550-555. PubMed ID: 33583686
[TBL] [Abstract][Full Text] [Related]
4. New Onset of DiabetEs in aSsociation with pancreatic ductal adenocarcinoma (NODES Trial): protocol of a prospective, multicentre observational trial.
Illés D; Ivány E; Holzinger G; Kosár K; Adam MG; Kamlage B; Zsóri G; Tajti M; Svébis MM; Horváth V; Oláh I; Márta K; Váncsa S; Zádori N; Szentesi A; Czakó B; Hegyi P; Czakó L
BMJ Open; 2020 Nov; 10(11):e037267. PubMed ID: 33444177
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. New-Onset or Exacerbation of Diabetes Mellitus Is a Clue to the Early Diagnosis of Pancreatic Cancer.
Takikawa T; Kikuta K; Kume K; Hamada S; Miura S; Yoshida N; Hongo S; Tanaka Y; Matsumoto R; Sano T; Ikeda M; Iseki M; Unno M; Masamune A
Tohoku J Exp Med; 2020 Dec; 252(4):353-364. PubMed ID: 33342915
[TBL] [Abstract][Full Text] [Related]
7. Diabetic Ketoacidosis as the Initial Presenting Symptom of Pancreatic Adenocarcinoma: A Discussion about Screening Utilizing ENDPAC Scoring Coupled with CT Scans and Endoscopic Ultrasound.
Menakuru SR; Priscu A; Dhillon VS; Salih A
Case Rep Oncol; 2022; 15(3):942-949. PubMed ID: 36636678
[TBL] [Abstract][Full Text] [Related]
8. Blood-based Migration Signature Biomarker Panel Discriminates Early Stage New Onset Diabetes related Pancreatic Ductal Adenocarcinoma from Type 2 Diabetes.
Balasenthil S; Liu S; Dai J; Bamlet WR; Petersen G; Chari ST; Maitra A; Chen N; Sen S; McNeill Killary A
Clin Chim Acta; 2023 Nov; 551():117567. PubMed ID: 37774897
[TBL] [Abstract][Full Text] [Related]
9. United Kingdom Early Detection Initiative (UK-EDI): protocol for establishing a national multicentre cohort of individuals with new-onset diabetes for early detection of pancreatic cancer.
Oldfield L; Stott M; Hanson R; Jackson RJ; Reynolds W; Chandran-Gorner V; Van Der Meer R; Alison L; Tejeiro R; Purewal T; Ghaneh P; Palmer D; Greenhalf W; Halloran C; Costello E
BMJ Open; 2022 Oct; 12(10):e068010. PubMed ID: 36216424
[TBL] [Abstract][Full Text] [Related]
10. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals.
Kulkarni NM; Mannelli L; Zins M; Bhosale PR; Arif-Tiwari H; Brook OR; Hecht EM; Kastrinos F; Wang ZJ; Soloff EV; Tolat PP; Sangster G; Fleming J; Tamm EP; Kambadakone AR
Abdom Radiol (NY); 2020 Mar; 45(3):729-742. PubMed ID: 31768594
[TBL] [Abstract][Full Text] [Related]
11. Model to Determine Risk of Pancreatic Cancer in Patients With New-Onset Diabetes.
Sharma A; Kandlakunta H; Nagpal SJS; Feng Z; Hoos W; Petersen GM; Chari ST
Gastroenterology; 2018 Sep; 155(3):730-739.e3. PubMed ID: 29775599
[TBL] [Abstract][Full Text] [Related]
12. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
13. Validation of the Enriching New-Onset Diabetes for Pancreatic Cancer Model: A Retrospective Cohort Study Using Real-World Data.
Boursi B; Patalon T; Webb M; Margalit O; Beller T; Yang YX; Chodick G
Pancreas; 2022 Feb; 51(2):196-199. PubMed ID: 35404897
[TBL] [Abstract][Full Text] [Related]
14. A Prospective Study to Establish a New-Onset Diabetes Cohort: From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer.
Maitra A; Sharma A; Brand RE; Van Den Eeden SK; Fisher WE; Hart PA; Hughes SJ; Mather KJ; Pandol SJ; Park WG; Feng Z; Serrano J; Rinaudo JAS; Srivastava S; Chari ST;
Pancreas; 2018; 47(10):1244-1248. PubMed ID: 30325864
[TBL] [Abstract][Full Text] [Related]
15. Validation of the Enriching New-Onset Diabetes for Pancreatic Cancer Model in a Diverse and Integrated Healthcare Setting.
Chen W; Butler RK; Lustigova E; Chari ST; Wu BU
Dig Dis Sci; 2021 Jan; 66(1):78-87. PubMed ID: 32112260
[TBL] [Abstract][Full Text] [Related]
16. Determining the feasibility of calculating pancreatic cancer risk scores for people with new-onset diabetes in primary care (DEFEND PRIME): study protocol.
Claridge H; Price CA; Ali R; Cooke EA; de Lusignan S; Harvey-Sullivan A; Hodges C; Khalaf N; O'Callaghan D; Stunt A; Thomas SA; Thomson J; Lemanska A
BMJ Open; 2024 Jan; 14(1):e079863. PubMed ID: 38262635
[TBL] [Abstract][Full Text] [Related]
17. Computerized tomography scan in pre-diagnostic pancreatic ductal adenocarcinoma: Stages of progression and potential benefits of early intervention: A retrospective study.
Singh DP; Sheedy S; Goenka AH; Wells M; Lee NJ; Barlow J; Sharma A; Kandlakunta H; Chandra S; Garg SK; Majumder S; Levy MJ; Takahashi N; Chari ST
Pancreatology; 2020 Oct; 20(7):1495-1501. PubMed ID: 32950386
[TBL] [Abstract][Full Text] [Related]
18. Imaging of the Pancreas in New-Onset Diabetes: A Prospective Pilot Study.
Wu BU; Lustigova E; Chen Q; Dong EY; Maitra A; Chari ST; Feng Z; Rinaudo JA; Matrisian LM; Parker RA; ;
Clin Transl Gastroenterol; 2022 Jun; 13(6):e00478. PubMed ID: 35333778
[TBL] [Abstract][Full Text] [Related]
19. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
20. Multicenter randomized controlled trial and registry study to assess the safety and efficacy of the NanoKnife® system for the ablation of stage 3 pancreatic adenocarcinoma: overview of study protocols.
Narayanan G; Bilimoria MM; Hosein PJ; Su Z; Mortimer KM; Martin RCG
BMC Cancer; 2021 Jul; 21(1):785. PubMed ID: 34233640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]